|
Selected by volunteers, not all presenters are committed.
Disclosures for each Presentation can be found through the Program/Itinerary Planner
Late-Breaking Clinical Trials
JUPITER - Rosuvastatin in the Prevention of Cardiovascular Events Among 17,802 Men and Women with Elevated Levels of C-Reactive Protein
Paul M. Ridker
Brigham and Women’s Hospital
Boston, Mass.
ATLAS ACS-TIMI 46 - Randomized Comparison of Rivaroxaban, an Oral Direct Factor Xa Inhibitor, with Placebo in Patients with Acute Coronary Syndromes
C. Michael Gibson
Beth Israel Deaconess Medical Center
Boston, Mass.
THINRS - A Prospective Randomized Controlled Trial of the Impact of Home INR Testing on Clinical Outcomes: The Home INR Study, VA Cooperative Study #481
Alan K. Jacobson
Loma Linda University and VA Medical Center
Loma Linda, Calif.
David Matchar
Duke University and Durham VA Medical Center
Raleigh Durham, N.C.
APPROACH - Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in Type 2 Diabetes Patients with Cardiovascular History
Richard W. Nesto
Lahey Clinic
Burlington, Mass.
SEARCH - Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine): Randomized Comparison of Folic Acid 2 mg Plus Vitamin B12 1 mg Daily versus Placebo for 7 Years in 12,064 Myocardial Infarction Survivors
Rory Collins and Jane Armitage
University of Oxford
Oxford, United Kingdom
PHS II - A Randomized Factorial Trial of Vitamins E and C in the Prevention of Cardiovascular Disease and Mortality in Men: The Physicians’ Health Study II
Michael Gaziano
Brigham and Women’s Hospital
Boston, Mass.
ACTION-HF - Morbidity and Mortality Outcomes from Aerobic Exercise Training in Heart Failure: Results of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) Study
David Whellan
Jefferson Medical College
Philadelphia, PA
I PRESERVE - A Randomized Double-Blind Placebo-Controlled Trial of Irbesartan in the Treatment of Heart Failure in Patients with Preserved Ejection Fraction
Barry M Massie
University of California, San Francisco
San Francisco, Calif.
Peter Carson
VA Medical Center
Washington, D.C.
International Congress on Imaging
COURAGE Revisited: Can Noninvasive Identification of Ischemia Identify a Long-term Therapeutic Benefit of CABG or PCI versus Medical Therapy
Rory Hachamovitch
Cedars-Sinai Medical Center,
Los Angeles, Calif.
Left Atrial Volume Index and Left Ventricular Geometry Independently Predict Mortality in 47,865 Patients with Preserved Ejection Fraction
Dharmendrakumar Patel
Ochsner Clinic Foundation
New Orleans, La.
Diagnostic Accuracy of Non-invasive 64-row Computed Tomographic Coronary Angiography (CCTA) Compared with Myocardial Perfusion Imaging (MPI): The PICTURE Study, A Prospective Multicenter Trial
Matthew Budoff
Los Angeles Biomedical Research
Los Angeles, Calif.
Left Ventricular Diastolic Function Impacts Age Based Differences in Exercise Capacity
Jasmine Grewal
Mayo Clinic
Toronto, Canada
Identification of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging as a Major Risk Factor for Sudden Death in Hypertrophic Cardiomyopathy
Ronen Rubinshtein
Mayo Clinic
Rochester, Minn.
The Amount of Myocardial Fibrosis by Contrast-Enhanced Magnetic Resonance Imaging Predicts Mortality Late after Aortic Valve Replacement in Patients with Severe Aortic Valve Disease: Validation against Quantitative Histopathology
Clerio Azevedo
Heart Institute (InCor) University of São Paulo Medical School
São Paulo, Brazil
Aortic Valve Calcification is Prospectively Associated with Primary Cardiovascular Events Independent of Subclinical Coronary Artery Disease Severity: the Multi-Ethnic Study of Atherosclerosis (MESA)
David Owens
University of Washington
Seattle, Wash.
Inherited Heart Disease
MicroRNA Control of Heart Disease: From New Biology to New Therapeutics
Eric Olson
UT Southwestern Medical Center at Dallas
Dallas, Texas
Important Role of Positive Family History of Sudden Death in Risk Stratification and Prevention of Death with the Implantable Defibrillator in Patients with Hypertrophic Cardiomyopathy
J. Martijn Bos
Mayo Clinic
Rochester, Minn.
Integrated Network and Microarray Analysis to Identify New Biomarkers of Heart Failure after Myocardial Infarction
Yvan Devaux and Daniel Wagner
CRP-Sante
Luxembourg, Luxembourg
Leukocyte Telomere Length is Preserved with Age in Adults Who Exercise and is Related to Vascular Endothelial Function
Thomas La Rocca
University of Colorado
Boulder, Colo.
Impact of Adding a Single Allele in the 9p21 Locus to Traditional Risk Factors on Risk Classification for Coronary Heart Disease and Implications for Lipid-Modifying Therapy in the White Population of the Atherosclerosis Risk in Communities (ARIC) Study
Ariel Brautbar
Baylor College of Medicine
Houston, Texas
Significant Single Nucleotide Polymorphism Associated with Atrial Fibrillation Located on Chromosome 4q25 in a Whole Genome Association Study and Association with Left Atrial Gene Expression
Mina Chung
Cleveland Clinic Foundation
Cleveland, Ohio
Cytochrome P450 Genetic Variants Predict Cardiovascular Outcomes following Treatment with Clopidogrel but not with Prasurgrel
Jessica Mega
Brigham and Women’s Hospital
Boston, Mass.
Heart Failure
Hypertension and New Onset Heart Failure: Changing Population Attributable Risk
Donald M Lloyd-Jones
Northwestern University
Chicago, Ill.
Amyloidosis: Where Are We Now?
Rodney Falk
Harvard Vanguard Medical Associates/Brigham and Women's Hospital
Boston, Mass.
Cardiac Resynchronisation Therapy in Elderly Patients: Outcome Data. A Secondary Analysis of CARE-HF
Christophe Leclercq
University Hospital
Rennes, France
Diagnostic Approach to Heart Failure with Normal Ejection Fraction in the Community
Carolyn Lam
Mayo Clinic & Foundation
Rochester, Minn.
Medicare Beneficiaries with Mild to Severe Heart Failure See 15-23 Different Providers Annually
Robert Page
University of Colorado Denver, School of Pharmacy
Denver, Colo.
|
Print
Email
